Written question asked by Baroness Merron (Labour) on Tuesday, 6 February 2024, in the House of Lords. It was due for an answer on Tuesday, 20 February 2024. It was answered by Lord Markham (Conservative) on Tuesday, 13 February 2024 on behalf of the Department of Health and Social Care.
Osteoporosis: Screening
- Question
-
To ask His Majesty's Government whether they are considering using the new screening technology, developed by OsteoSight, for estimating bone mineral density from routine X-rays that has been approved by the Food and Drug Administration in the United States to give earlier diagnosis of osteoporosis.
- Answer
-
OsteoSight is not a registered product with the Medicines and Healthcare Products Regulatory Agency, therefore the Government is not currently considering the use of this technology. However, we will continue to explore areas where artificial intelligence can be deployed in health and care to support clinicians, transform patient experience and improve outcomes.
Secondary information
- Type
- Written question
- Reference
- HL2250
- Session
- 2023-24
- Subjects
- Screening Technology X-rays Osteoporosis
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2024-02-13 13:36:28 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2023-24/HL2250
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2023-24/HL2250
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2023-24/HL2250